MedPath

Agreement and Precision of Capstesia, a New Smarphone Application for PPV and CO Monitoring

Completed
Conditions
Surgery
Registration Number
NCT03137901
Lead Sponsor
Erasme University Hospital
Brief Summary

This study test the agreement and precision of Pulse Pressure Variation (PPV) and Cardiac Output (CO) obtained by the Android application Capstesia™ against another pulse contour CO monitoring ( EV-1000, Edwards Lefesciences, USA)

Detailed Description

Pulse pressure variation (PPV) remains a good predictor of fluid responsiveness in the OR. However, PPV can be time-consuming to calculate (manual determination), is not always displayed on monitoring screens nor reliable through visual assessment and needs additional devices to be displayed. A new Android application (Captesia) automatically calculates the PPV utilizing a digital photograph of the arterial waveform from the monitor. The application determines the PPV by selecting peaks and troughs of the arterial curve.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • patients scheduled for major surgery which requires a CO and PPV monitoring as standard of care
Exclusion Criteria
  • patients with arrhythmias like atrial fibrillation
  • patients with valvular insufficiency

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Agreement and precision of PPV and CO during 5 surgical phases (postinduction, pre incision, postincision, end of surgery and at least one episode of hypotension)during surgery

We will compare PPV and CO given with the EV-1000 and the capstesia app at different phases of the surgery

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Erasme

🇧🇪

Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath